News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Jain Rita
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2023 |
4
| Jain Rita (Director) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Granted 66,000 options to buy
@ $9.67, valued at
$638.2k
|
|
| 01/05/2023 |
3
| Jain Rita (Director) has filed a Form 3 on Provention Bio, Inc. |
| 10/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/29/2022 |
4
| Jain Rita (EVP, Chief Medical Officer) has filed a Form 4 on ChemoCentryx, Inc.|
Txns:
| Exercised 5,251 restricted stock units
@ $0 |
|
| 02/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/31/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 03/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/25/2021 |
4
| Jain Rita (Chief Medical Officer) has filed a Form 4 on Immunovant, Inc.|
Txns:
| Granted 20,000 shares
@ $0
Granted 220,000 options to buy
@ $42.19, valued at
$9.3M
|
|
| 01/14/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/26/2020 |
4
| Jain Rita (Director) has filed a Form 4 on ChemoCentryx, Inc.|
Txns:
| Granted 2,888 options to buy
@ $59.73, valued at
$172.5k
Granted 4,660 restricted stock units
@ $0 |
|
| 03/31/2020 |
4
| Jain Rita (Director) has filed a Form 4 on ChemoCentryx, Inc.|
Txns:
| Exercised 5,251 restricted stock units
@ $0 |
|
| 05/23/2019 |
4
| Jain Rita (Director) has filed a Form 4 on ChemoCentryx, Inc.|
Txns:
| Granted 7,724 shares
@ $0
Granted 12,287 options to buy
@ $11.6, valued at
$142.5k
|
|
| 04/12/2019 |
4
| Jain Rita (SVP, Chief Medical Officer) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Disposed/sold 4,409 shares
@ $7.7, valued at
$33.9k
|
|
| 03/29/2019 |
4
| Jain Rita (Director) has filed a Form 4 on ChemoCentryx, Inc.|
Txns:
| Granted 15,753 restricted stock units
@ $0 |
|
| 03/29/2019 |
3
| Jain Rita (Director) has filed a Form 3 on ChemoCentryx, Inc. |
| 03/05/2019 |
4
| Jain Rita (SVP, Chief Medical Officer) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 80,000 shares
@ $0
Granted 115,000 options to buy
@ $7.28, valued at
$837.2k
|
|
| 12/13/2018 |
4
| Jain Rita (SVP, Chief Medical Officer) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 8,659 shares
@ $8.94, valued at
$77.4k
|
|
| 03/02/2018 |
4
| Jain Rita (SVP, Chief Medical Officer) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 29,400 shares
@ $0
Granted 41,800 options to buy
@ $14.3, valued at
$597.7k
|
|
| 06/02/2017 |
4
| Jain Rita (SVP, Chief Medical Officer) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 200,000 options to buy
@ $13.4, valued at
$2.7M
|
|
| 06/01/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|